Skip to main content
| News

LCB lands major contract

11.06.2021

LCB Sàrl has developed i4, a communication module for machines at the service of Industry 4.0. The Jura-based company has created a partnership with the French group HLP, which specializes in the digital transformation of companies. This success is also the result of the Basel Area Business & Innovation network.

David Maître, founder of LCB (right), with Albert Hilber from i4Challenge (img: Dave Joly)

LCB Sàrl has developed i4, a communication module for machines at the service of Industry 4.0. The Jura-based company has created a partnership with the French group HLP, which specializes in the digital transformation of companies. This success is also the result of the Basel Area Business & Innovation network.

The agency for the promotion of the business location and innovation organizes the i4Challenge, a competition for start-ups and SMEs in the Industry 4.0 sector. As one of the winners in 2019, LCB Sàrl was thus able to participate in the tri-national Industry 4.0 trade fair (BE4.0) in Mulhouse. It was on this occasion that the meeting with HLP took place. “If while walking around the BE4.0 fair, I had not decided to stop at the HLP booth, none of this would have happened,” recalls David Maître of LCB.

Within the framework of the partnership with HLP, LCB has already been able to win new customers. These include a multinational group with more than 40 production sites in America, the EU and Asia. For LCB, this represents more than 1500 boxes and therefore more than 1500 machines to connect.

David Maître founded LCB Sàrl in 1997. “We have been evolving in the field of Industry 4.0 for over 20 years. Only it wasn’t called that back then,” David Maître said in an interview on the occasion of his victory at i4Challenge 2019. His company solves “industry-related technical problems where standard solutions don’t apply, or where processes need to be adjusted.” With its i4 modules, LCB Sàrl wants to propose to companies its solutions for the communication of production means.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.